
Keywords: HL، لیپاز کبدی; DM − DL −, “Healthy” obese patients, or patients without type 2 diabetes or dyslipidaemia; DM − DL +, Dyslipidemic obese patients; DM + DL +, Obese patients with type 2 diabetes and dyslipidaemia; HL, Hepatic lipase; VLDLr, Very-Low-Density Lipoprotein